glp 1 nasal spray Intranasal GLP-1 medication from Orexo shows positive results in preclinical trial GLP-1 Research Peptides — Semaglutide

Transforming growth factor beta 1 and renal injury following subtotal nephrectomy in the rat: role of the renin-angiotensin system

b , cAMP accumulation studies using GLP-1 and TT-OAD2 as the agonist in wild-type HEK293 cells and HEK293 cells in which G s/olf (G s ) or all G i/o/z (G i/o/z ) have been depleted using CRISPRCas9

Rouille Y, Martin S, and Steiner DF

GCGR/GIPR/GLP-1R agonist: OR: 0.21, 95%CI: 0.080.56, P = 1.98 10 3 ) and the association remained consistent in the replication dataset (GIPR/GLP-1R agonist: OR: 0.16, 95%CI: 0.070.40, P = 7.90 10 5

Disclaimer: GLP-1 must be prescribed by a licensed medical professional

They're offered in several brand name forms, like Ozempic, where semaglutide is the main substance, or Zepbound, where tirzepatide is the main substance